Similar Items: Evaluation of Glutathione peroxidase activity and Angiotensin II as monitoring biomarkers of long-term therapy in Iraqi patients with prostate cancer
- Fractionation gives therapeutic benefit in animal model of [Lu]Lu-PSMA-617 therapy of prostate cancer
- Predictors of acute genitourinary toxicity in real-time image-gated spot-scanning proton beam therapy for prostate cancer
- Angiotensin‐converting enzyme 2 enhances megalin‐mediated albumin endocytosis in proximal tubule cells by restraining Angiotensin II/AT1R
- Identification of genetically predicted protein biomarkers and drug targets for prostate cancer via Mendelian randomization
- Targeting the RNA-binding motif protein 15 suppresses prostate cancer progression and hormone therapy resistance by promoting androgen receptor degradation
- Cost-effectiveness analysis of intensity modulated radiation therapy versus robot-assisted radical prostatectomy for patients with low-risk prostate cancer in Japan